The manufacturing of high-demand plasma-derived therapies from plasma fractionation, namely Immunoglobulins for Primary Immunodeficiencies and Autoimmune Neurological conditions, and Albumin for ...

Rising demand for plasma-derived products in chronic disease management. Plasma Fractionation Market growth was valued at 25.77 Billion USD in 2023. Plasma Fractionation Market Industry is ...

The company’s three discovery platforms are a foundation for its research. Plasma fractionation – Our clinical research activities make products available to patients worldwide and identify ...

Rising demand for plasma-derived products in chronic disease management. Plasma Fractionation Market growth was valued at 25.77 Billion USD in 2023. Plasma Fractionation Market Industry is ...

The economics of plasma fractionation are complex; however, we can demonstrate the interdependent nature of the manufacturing of multiple therapies to sustain the viability of a company (see ...

Albumin is one of the three key plasma-derived therapies that manufacturers must produce from the raw starting material in order for the fractionation operation to thrive. Because source plasma is ...